1. Home
  2. BIRK vs ASND Comparison

BIRK vs ASND Comparison

Compare BIRK & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Birkenstock Holding plc

BIRK

Birkenstock Holding plc

HOLD

Current Price

$42.67

Market Cap

8.8B

Sector

N/A

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$209.26

Market Cap

12.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIRK
ASND
Founded
1774
2006
Country
United Kingdom
Denmark
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
12.8B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
BIRK
ASND
Price
$42.67
$209.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
15
Target Price
$64.69
$256.40
AVG Volume (30 Days)
2.9M
700.0K
Earning Date
02-19-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
83.10
N/A
EPS
2.19
N/A
Revenue
$2,460,904,611.00
$758,592,045.00
Revenue This Year
$14.52
$98.90
Revenue Next Year
$14.40
$83.74
P/E Ratio
$19.06
N/A
Revenue Growth
16.22
97.46
52 Week Low
$38.16
$118.03
52 Week High
$62.66
$229.94

Technical Indicators

Market Signals
Indicator
BIRK
ASND
Relative Strength Index (RSI) 50.67 51.33
Support Level $40.59 $207.28
Resistance Level $43.02 $215.98
Average True Range (ATR) 1.80 7.30
MACD -0.22 0.31
Stochastic Oscillator 33.62 67.56

Price Performance

Historical Comparison
BIRK
ASND

About BIRK Birkenstock Holding plc

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Share on Social Networks: